600721 Stock Overview
Engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600721 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.99 |
| 52 Week High | CN¥8.67 |
| 52 Week Low | CN¥4.31 |
| Beta | 0.19 |
| 1 Month Change | -2.10% |
| 3 Month Change | -3.45% |
| 1 Year Change | -9.69% |
| 3 Year Change | -6.68% |
| 5 Year Change | 1.01% |
| Change since IPO | 10.80% |
Recent News & Updates
Shareholders Can Be Confident That Xinjiang Bai Hua Cun Pharma TechLtd's (SHSE:600721) Earnings Are High Quality
Nov 01
The Price Is Right For Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHSE:600721) Even After Diving 26%
Sep 04Recent updates
Shareholders Can Be Confident That Xinjiang Bai Hua Cun Pharma TechLtd's (SHSE:600721) Earnings Are High Quality
Nov 01The Price Is Right For Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHSE:600721) Even After Diving 26%
Sep 04Investors Still Waiting For A Pull Back In Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHSE:600721)
Jun 22We Think Xinjiang Bai Hua Cun Pharma TechLtd's (SHSE:600721) Profit Is Only A Baseline For What They Can Achieve
May 02Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd's (SHSE:600721) P/S Is Still On The Mark Following 34% Share Price Bounce
Mar 08Shareholder Returns
| 600721 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.6% | -1.9% | -0.6% |
| 1Y | -9.7% | -5.7% | 8.3% |
Return vs Industry: 600721 underperformed the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 600721 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 600721 volatility | |
|---|---|
| 600721 Average Weekly Movement | 6.8% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600721 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600721's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 759 | Hui Huang | www.xjbhc.net |
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021.
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd Fundamentals Summary
| 600721 fundamental statistics | |
|---|---|
| Market cap | CN¥2.68b |
| Earnings (TTM) | CN¥19.23m |
| Revenue (TTM) | CN¥394.19m |
139.2x
P/E Ratio6.8x
P/S RatioIs 600721 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600721 income statement (TTM) | |
|---|---|
| Revenue | CN¥394.19m |
| Cost of Revenue | CN¥245.83m |
| Gross Profit | CN¥148.37m |
| Other Expenses | CN¥129.13m |
| Earnings | CN¥19.23m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 12, 2025
| Earnings per share (EPS) | 0.05 |
| Gross Margin | 37.64% |
| Net Profit Margin | 4.88% |
| Debt/Equity Ratio | 0% |
How did 600721 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 05:54 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |